Nuveen Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $320K | Hold |
55,607
| – | – | ﹤0.01% | 3114 |
|
|
2024
Q3 | $576K | Hold |
55,607
| – | – | ﹤0.01% | 2964 |
|
|
2024
Q2 | $721K | Sell |
55,607
-33,780
| -38% | -$438K | ﹤0.01% | 2859 |
|
|
2024
Q1 | $1.56M | Buy |
89,387
+33,780
| +61% | +$590K | ﹤0.01% | 2506 |
|
|
2023
Q4 | $523K | Buy |
55,607
+106
| +0.2% | +$997 | ﹤0.01% | 2985 |
|
|
2023
Q3 | $620K | Sell |
55,501
-595
| -1% | -$6.65K | ﹤0.01% | 2770 |
|
|
2023
Q2 | $1.2M | Hold |
56,096
| – | – | ﹤0.01% | 2569 |
|
|
2023
Q1 | $2.27M | Sell |
56,096
-5,284
| -9% | -$214K | ﹤0.01% | 2281 |
|
|
2022
Q4 | $2.86M | Sell |
61,380
-9,095
| -13% | -$423K | ﹤0.01% | 2226 |
|
|
2022
Q3 | $3.66M | Sell |
70,475
-1,543
| -2% | -$80K | ﹤0.01% | 2077 |
|
|
2022
Q2 | $3.4M | Sell |
72,018
-73,462
| -50% | -$3.47M | ﹤0.01% | 2168 |
|
|
2022
Q1 | $9.67M | Buy |
145,480
+49,322
| +51% | +$3.28M | ﹤0.01% | 1662 |
|
|
2021
Q4 | $6.4M | Buy |
96,158
+14,612
| +18% | +$972K | ﹤0.01% | 1967 |
|
|
2021
Q3 | $4.76M | Buy |
81,546
+390
| +0.5% | +$22.8K | ﹤0.01% | 2242 |
|
|
2021
Q2 | $3.57M | Sell |
81,156
-3,863
| -5% | -$170K | ﹤0.01% | 2416 |
|
|
2021
Q1 | $4.19M | Sell |
85,019
-2,454
| -3% | -$121K | ﹤0.01% | 2246 |
|
|
2020
Q4 | $3.68M | Sell |
87,473
-3,114
| -3% | -$131K | ﹤0.01% | 2223 |
|
|
2020
Q3 | $4.15M | Sell |
90,587
-21,527
| -19% | -$985K | ﹤0.01% | 2021 |
|
|
2020
Q2 | $5.63M | Buy |
112,114
+13,282
| +13% | +$667K | ﹤0.01% | 1831 |
|
|
2020
Q1 | $5.08M | Sell |
98,832
-18,819
| -16% | -$968K | ﹤0.01% | 1707 |
|
|
2019
Q4 | $7.27M | Sell |
117,651
-92,118
| -44% | -$5.69M | ﹤0.01% | 1778 |
|
|
2019
Q3 | $12.6M | Buy |
209,769
+12,018
| +6% | +$722K | 0.01% | 1416 |
|
|
2019
Q2 | $16.7M | Buy |
+197,751
| New | +$16.7M | 0.01% | 1267 |
|